- Home
- Asia Pacific Bone Marrow Biopsy Market
Asia-Pacific Bone Marrow Biopsy Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-55 | No of pages: 213 | Format:
Asia-Pacific bone marrow biopsy market is projected to register CAGR of 6.3% in the forecast period of 2018 to 2027. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2018 to 2027.
Market Segmentation:
Asia-Pacific Bone Marrow Biopsy Market, By Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of Asia-Pacific bone marrow biopsy market are:
Adequate reimbursement policies
Increasing awareness program and initiative
Market Players:
The key market players for Asia-Pacific bone marrow biopsy market are listed below:
BD
Argon Medical
Johnson & Johnson Services, Inc.
Cardinal Health
Shanghai Mekon Medical Devices Co., Ltd.
Medtronic
Merit Medical Systems
Teleflex Incorporated
Cook Medical (A subsidiary of Cook Group)
Somatex Medical Technologies GmbH
GPC Medical Ltd.
ST. Stone Medical Devices Pvt. Ltd.
Suretech Medical Inc.
Zhejiang Kindly Medical Devices Co., Ltd.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF ASIA-PACIFIC BONE MARROW BIOPSY MARKET 23
1.4 CURRENCY AND PRICING 25
1.5 LIMITATIONS 25
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 DBMR TRIPOD DATA VALIDATION MODEL 31
2.5 MULTIVARIATE MODELLING 34
2.6 PRODUCT TYPE LIFELINE CURVE 35
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.8 DBMR MARKET POSITION GRID 37
2.9 VENDOR SHARE ANALYSIS 38
2.10 SECONDARY SOURCES 39
2.11 ASSUMPTIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 44
5 REIMBURSEMENT SCENARIO 45
6 PRICING ANALYSIS 46
7 MARKET OVERVIEW 51
7.1 DRIVERS 53
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASE SPECIALLY CANCER 53
7.1.2 INCREASING DIAGNOSIS RATE OF EARLY DETECTION 53
7.1.3 ADEQUATE REIMBURSEMENT POLICIES 54
7.1.4 INCREASING AWARENESS PROGRAM AND INITIATIVE 54
7.2 RESTRAINTS 56
7.2.1 HIGH COST OF BONE MARROW BIOPSY TESTING 56
7.2.2 STRINGENT REGULATORY FRAMEWORK AND GUIDELINES 56
7.3 OPPORTUNITIES 57
7.3.1 EXTENSIVE RESEARCH AND DEVELOPMENT ACTIVITIES 57
7.3.2 INTRODUCTION OF CUTTING EDGE BIOPSY DEVICES 57
7.3.3 HUGE MARKET POTENTIAL IN DEVELOPING COUNTRIES 57
7.4 CHALLENGES 58
7.4.1 LACK OF MEDICAL INFRASTRUCTURE IN DEVELOPING COUNTRIES 58
7.4.2 SIDE EFFECTS AND RISKS ASSOCIATED WITH BONE MARROW BIOPSY 58
7.4.3 SHORTAGE OF SKILLED PHYSICIAN 58
8 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY PRODUCT TYPE 60
8.1 OVERVIEW 61
8.2 NEEDLES 64
8.2.1 BY TYPE 64
8.2.1.1 JAMSHIDI NEEDLE 64
8.2.1.2 TREPHINE BIOPSY NEEDLES 64
8.2.1.3 SALAH BONE MARROW ASPIRATION NEEDLE 64
8.2.1.4 KLIMA STERNAL NEEDLE 65
8.2.2 BY MODALITY 65
8.2.2.1 DISPOSABLE 65
8.2.2.2 REUSABLE 65
8.2.3 BY ERGONOMICS 65
8.2.3.1 SHARP 65
8.2.3.2 CHIBA 66
8.2.3.3 FRANSEEN 66
8.2.3.4 QUINCKE 66
8.2.3.5 BLUNT 66
8.2.3.6 OTHERS 66
8.3 INSTRUMENTS 66
8.3.1 ANALYZER 66
8.3.2 FLOW CYTOMETER 66
8.3.3 PCR MACHINE 67
8.3.4 OTHERS 67
8.4 BIOPSY GUN 67
8.5 PROCEDURE TRAYS 67
8.6 OTHERS 67
9 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY PROCEDURE TYPE 68
9.1 OVERVIEW 69
9.2 HIP BIOPSY 72
9.3 BREASTBONE (STERNUM) BIOPSY 72
9.4 PERCUTANEOUS TREPHINE BIOPSY 72
9.5 TIBIA (SHIN) BIOPSY 72
9.6 OTHERS 72
10 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY BIOPSY TYPE 73
10.1 OVERVIEW 74
10.2 CORE NEEDLE BIOPSY 77
10.3 VACUUM-ASSISTED BIOPSY (VAB) 77
10.4 FINE NEEDLE ASPIRATION BIOPSY 77
11 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY SITE 78
11.1 OVERVIEW 79
11.2 POSTERIOR ILIAC CREST 82
11.3 ANTERIOR ILIAC CREST 82
11.4 CALCANEUS 82
11.5 DISTAL TIBIA 82
11.6 PROXIMAL HUMERUS 82
11.7 PROXIMAL TIBIA 82
11.8 OTHERS 82
12 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY TECHNIQUE 83
12.1 OVERVIEW 84
12.2 FLOW CYTOMETRY 87
12.3 FLUORESCENCE IN SITU HYBRIDIZATION (FISH) 87
12.4 POLYMERASE CHAIN REACTION (PCR) 87
12.5 KARYOTYPE TEST 87
12.6 OTHERS 87
13 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY AGE 88
13.1 OVERVIEW 89
13.2 GERIATRIC 92
13.3 ADULT 92
13.4 PEDIATRIC 92
14 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY APPLICATION 93
14.1 OVERVIEW 94
14.2 LYMPHOMA DISEASE 97
14.3 LEUKEMIA 97
14.3.1 CHRONIC LYMPHOCYTIC LEUKEMIA 97
14.3.2 ACUTE MYELOID LEUKEMIA 97
14.3.3 CHRONIC MYELOID LEUKEMIA 97
14.3.4 ACUTE LYMPHOCYTIC LEUKEMIA 97
14.4 POLYCYTHEMIA VERA 97
14.5 MULTIPLE MYELOMA 98
14.6 THROMBOCYTHEMIA 98
14.7 MYELOFIBROSIS 98
14.8 APLASTIC ANEMIA 98
14.9 OTHERS 98
15 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY END USER 99
15.1 OVERVIEW 100
15.2 HOSPITALS 103
15.3 DIAGNOSTIC CENTERS 103
15.4 AMBULATORY SURGICAL CENTERS 103
15.5 ACADEMIC AND RESEARCH ORGANIZATIONS 103
15.6 OTHERS 103
16 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY DISTRIBUTION CHANNEL 104
16.1 OVERVIEW 105
16.2 DIRECT TENDER 108
16.3 RETAIL SALES 108
17 ASIA-PACIFIC BONE MARROW BIOPSY MARKET, BY GEOGRAPHY 109
17.1 OVERVIEW 110
17.2 ASIA-PACIFIC 111
17.2.1 CHINA 121
17.2.2 JAPAN 126
17.2.3 INDIA 131
17.2.4 SOUTH KOREA 136
17.2.5 AUSTRALIA 141
17.2.6 INDONESIA 146
17.2.7 THAILAND 151
17.2.8 MALAYSIA 156
17.2.9 SINGAPORE 161
17.2.10 PHILIPPINES 166
17.2.11 TAIWAN 171
17.2.12 VIETNAM 176
17.2.13 REST OF ASIA-PACIFIC 181
18 ASIA-PACIFIC BONE MARROW BIOPSY MARKET: COMPANY LANDSCAPE 182
18.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 182
19 ASIA-PACIFIC BONE MARROW BIOPSY MARKET: SWOT ANALYSIS 183
19.1 SWOT ANALYSIS 183
19.1.1 STRENGTH: - WIDE PRODUCT PORTFOLIO 183
19.1.2 STRENGTH: - STRONG ASIA-PACIFIC PRESENCE 183
19.1.3 STRENGTH: - EXTENSIVE RESEARCH AND DEVELOPMENT ACTIVITIES 184
19.1.4 WEAKNESS: - SINGLE SUPPLIER 184
19.1.5 WEAKNESS: - PRODUCT RECALL 185
19.1.6 WEAKNESS: - OBSOLETE TECHNOLOGIES 185
19.1.7 OPPORTUNITY: - EXPANDING BUSINESS THOROUGH THEIR SUBSIDIARIES 185
19.1.8 OPPORTUNITY: - ACQUISITION 186
19.1.9 THREAT: - FDA STANDARDS/ REGULATORY AUTHORITIES STRINGENT RULES 186
19.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 186
20 COMPANY PROFILE 187
20.1 BD 187
20.1.1 COMPANY SNAPSHOT 187
20.1.2 REVENUE ANALYSIS 188
20.1.3 PRODUCT PORTFOLIO 188
20.1.4 RECENT DEVELOPMENT 188
20.2 MEDTRONICS 189
20.2.1 COMPANY SNAPSHOT 189
20.2.2 REVENUE ANALYSIS 190
20.2.3 PRODUCT PORTFOLIO 190
20.2.4 RECENT DEVELOPMENT 190
20.3 ARGON MEDICAL 191
20.3.1 COMPANY SNAPSHOT 191
20.3.2 PRODUCT PORTFOLIO 191
20.3.3 RECENT DEVELOPMENT 191
20.4 MERIT MEDICAL SYSTEMS 192
20.4.1 COMPANY SNAPSHOT 192
20.4.2 REVENUE ANALYSIS 193
20.4.3 PRODUCT PORTFOLIO 193
20.4.4 RECENT DEVELOPMENT 193
20.5 ZHEJIANG KINDLY MEDICAL DEVICES CO., LTD. 194
20.5.1 COMPANY SNAPSHOT 194
20.5.2 PRODUCT PORTFOLIO 194
20.5.3 RECENT DEVELOPMENT 194
20.6 CARDINAL HEALTH 195
20.6.1 COMPANY SNAPSHOT 195
20.6.2 REVENUE ANALYSIS 196
20.6.3 PRODUCT PORTFOLIO 196
20.6.4 RECENT DEVELOPMENT 196
20.7 COOK 197
20.7.1 COMPANY SNAPSHOT 197
20.7.2 PRODUCT PORTFOLIO 198
20.7.3 RECENT DEVELOPMENT 198
20.8 GPC MEDICAL LTD. 199
20.8.1 COMPANY SNAPSHOT 199
20.8.2 PRODUCT PORTFOLIO 199
20.8.3 RECENT DEVELOPMENTS 199
20.9 JOHNSON & JOHNSON SERVICES, INC. 200
20.9.1 COMPANY SNAPSHOT 200
20.9.2 REVENUE ANALYSIS 201
20.9.3 PRODUCT PORTFOLIO 201
20.9.4 RECENT DEVELOPMENT 201
20.10 SOMATEX MEDICAL TECHNOLOGIES GMBH 202
20.10.1 COMPANY SNAPSHOT 202
20.10.2 PRODUCT PORTFOLIO 202
20.10.3 RECENT DEVELOPMENT 202
20.11 ST. STONE MEDICAL DEVICES PVT. LTD. 203
20.11.1 COMPANY SNAPSHOT 203
20.11.2 PRODUCT PORTFOLIO 203
20.11.3 RECENT DEVELOPMENT 203
20.12 SURETECH MEDICAL INC. 204
20.12.1 COMPANY SNAPSHOT 204
20.12.2 PRODUCT PORTFOLIO 204
20.12.3 RECENT DEVELOPMENT 204
20.13 TELEFLEX INCORPORATED 205
20.13.1 COMPANY SNAPSHOT 205
20.13.2 REVENUE ANALYSIS 206
20.13.3 PRODUCT PORTFOLIO 206
20.13.4 RECENT DEVELOPMENT 206
21 QUESTIONNAIRE 207
22 CONCLUSION 212
23 RELATED REPORTS 213
Segmentation
Short Description
Asia-Pacific Bone Marrow Biopsy Market, By Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.) Industry Trends and Forecast to 2027
Market Definition:
Bone marrow is the delicate tissue inside the bones that make up blood cells. This includes red blood cells, white blood cells, and platelets. In bone marrow biopsy collection and examination of the soft tissue or sample is done under the microscope by a pathologist. There can be many reasons for conducting bone marrow biopsy of the patient for example anemia, abnormal bleeding, and cancers that have spread to the bone marrow and even unexplained fevers. A biopsy of the bone marrow consists of two steps-
The removal of fluid via a needle or aspiration
Taking a small volume of bone and marrow tissue, called a biopsy
The treatment takes about 10-15 minutes. Using a needle and syringe, the doctor will draw a small amount of fluid from the bone marrow. This fluid is littered with blood cells. Then there's the biopsy. A doctor uses a needle to take a bone marrow sample.
Market Segmentation:
The bone marrow biopsy market is segmented on the basis of product type, biopsy type, procedure type, site, technique, age, application, end user and distribution channel.
On the basis of product type, bone marrow biopsy market is segmented into needles, biopsy gun, procedure trays, instruments and others.
On the basis of biopsy type, bone marrow biopsy market is segmented into core needle biopsy, vacuum-assisted biopsy (VAB) and fine needle aspiration biopsy.
On the basis of procedure type, bone marrow biopsy market is segmented into hip biopsy, breastbone (sternum) biopsy, percutaneous trephine biopsy, tibia (shin) biopsy and others.
On the basis of site, bone marrow biopsy market is segmented into posterior iliac crest, anterior iliac crest, calcaneus, distal tibia, proximal tibia, proximal humerus and others.
On the basis of technique, bone marrow biopsy market is segmented into flow cytometry, fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), karyotype test and other.
On the basis of age, bone marrow biopsy market is segmented into geriatric, adult and pediatric.
On the basis of application, bone marrow biopsy market is segmented into lymphoma disease, leukemia, polycythemia vera, multiple myeloma, thrombocythemia, myelofibrosis, aplastic anemia and others.
On the basis of end user, bone marrow biopsy market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, academic and research organizations and others.
On the basis of distribution channel, bone marrow biopsy market is segmented into direct tender and retail sales.
Market Players
The key market players for Asia-Pacific bone marrow biopsy market are listed below:
BD
Argon Medical
Johnson & Johnson Services, Inc.
Cardinal Health
Shanghai Mekon Medical Devices Co., Ltd.
Medtronic
Merit Medical Systems
Teleflex Incorporated
Cook Medical (A subsidiary of Cook Group)
Somatex Medical Technologies GmbH
GPC Medical Ltd.
ST. Stone Medical Devices Pvt. Ltd.
Suretech Medical Inc.
Zhejiang Kindly Medical Devices Co., Ltd
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.